Insulin-like growth factor-I in women with hydatidiform mole and in normal pregnancy

Obstet Gynecol. 1998 Sep;92(3):431-4. doi: 10.1016/s0029-7844(98)00180-x.

Abstract

Objective: To compare molar and placental tissue insulin-like growth factor-I (IGF-I) levels and IGF-I messenger RNA (mRNA) expression and maternal serum IGF-I levels in molar and normal pregnancies of the same gestational length.

Methods: Tissue and serum total IGF-I were measured by radioimmunoassay, and tissue IGF-I mRNA expression was measured by a solution hybridization technique in samples from seven patients with hydatidiform mole in gestational weeks 8 through 14 and from 12 women with normal placentas undergoing induced abortion during weeks 8 through 12.

Results: Tissue and serum total IGF-I levels and tissue IGF-I mRNA expression were significantly lower in molar pregnancies than in pregnancies with normal placenta.

Conclusion: The lower levels of both IGF-I mRNA and of the IGF-I protein itself in hydatidiform mole indicates that the regulation of expression of IGF-I is on the transcriptional level. This finding may reflect a decreased production of the placental growth hormone variant in molar tissue.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Humans
  • Hydatidiform Mole / chemistry*
  • Insulin-Like Growth Factor I / analysis*
  • Insulin-Like Growth Factor I / genetics
  • Placenta / chemistry*
  • Pregnancy
  • RNA, Messenger / analysis
  • Uterine Neoplasms / chemistry*

Substances

  • RNA, Messenger
  • Insulin-Like Growth Factor I